Efficacy and safety of repetitive transcranial magnetic stimulation with different frequencies on neuropathic orofacial pain: a systematic literature review and meta-analysis
- PMID: 39801095
- PMCID: PMC11810666
- DOI: 10.22514/jofph.2024.013
Efficacy and safety of repetitive transcranial magnetic stimulation with different frequencies on neuropathic orofacial pain: a systematic literature review and meta-analysis
Abstract
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique used to treat neuropathic orofacial pain (NOP). This study aimed to evaluate the efficacy and safety of rTMS in managing NOP and reducing health risks. A comprehensive literature search was conducted in various databases, including PubMed, Physiotherapy Evidence Database (PEDro), the Cochrane Library, Web of Science, Embase and Clinical Trials.gov. Thirteen relevant articles were identified and assessed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the Cochrane Risk of Bias assessment tool. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was utilized to evaluate the evidence rating for the studies. The analysis of the thirteen randomized controlled trials, involving 355 eligible patients, demonstrated moderate evidence supporting the significant effect of rTMS in reducing pain intensity (Mean Difference (MD): -1.01, 95% Confidence Interval (CI) -2.39 to -1.48, p < 0.001) and improving the quality of life (QOL) based on various instruments (MD: -9.23, 95% CI -11.91 to -6.54, p < 0.001; MD: -2.1, 95% CI -3.74 to -0.45, p < 0.05). Patients also reported favorable improvements in global impression (MD: -0.54, 95% CI -1.02 to -0.07, p < 0.05) and sensory status (Standardized Mean Difference (SMD): -1.30, 95% CI -1.74 to -0.87, p < 0.001). However, there were no significant improvements in sleep quality (MD: -1.72, 95% CI -4.13 to 0.68, p > 0.05) or psychological status (p > 0.05). Overall, the study demonstrated that rTMS is an effective and safe way to reduce pain, improve QOL, enhance sensory status, and create a positive clinical impression in patients with NOP. Further research is needed to investigate the effects of rTMS on sleep and psychological well-being in individuals with NOP.
Keywords: Meta-analysis; Neuromodulation; Neuropathic orofacial pain; Rehabilitation; Repetitive transcranial magnetic stimulation.
©2024 The Author(s). Published by MRE Press.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The effect of repetitive transcranial magnetic stimulation on the Hamilton Depression Rating Scale-17 criterion in patients with major depressive disorder without psychotic features: a systematic review and meta-analysis of intervention studies.BMC Psychol. 2024 Sep 10;12(1):480. doi: 10.1186/s40359-024-01981-6. BMC Psychol. 2024. PMID: 39256851 Free PMC article.
-
The effect of repetitive transcranial magnetic stimulation for insomnia: a systematic review and meta-analysis.Sleep Med. 2021 Jan;77:226-237. doi: 10.1016/j.sleep.2020.05.020. Epub 2020 May 22. Sleep Med. 2021. PMID: 32830052
-
Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis.Lancet Neurol. 2025 May;24(5):413-428. doi: 10.1016/S1474-4422(25)00068-7. Lancet Neurol. 2025. PMID: 40252663
-
High Frequency Repetitive Transcranial Magnetic Stimulation Therapy For Chronic Neuropathic Pain: A Meta-analysis.Pain Physician. 2015 Nov;18(6):E1029-46. Pain Physician. 2015. PMID: 26606017
Cited by
-
Mechanisms for Orofacial Pain: Roles of Immunomodulation, Metabolic Reprogramming, Oxidative Stress and Epigenetic Regulation.Biomedicines. 2025 Feb 11;13(2):434. doi: 10.3390/biomedicines13020434. Biomedicines. 2025. PMID: 40002847 Free PMC article. Review.
References
-
- Fehér G, Nemeskéri Z, Pusch G, Zádori I, Bank G, Gurdán Z, et al. Chronic orofacial pain. Hungarian Medical Journal. 2019; 160: 1047–1056. (In Hungarian) - PubMed
-
- Olesen J. International classification of headache disorders. The Lancet Neurology. 2018; 17: 396–397. - PubMed
-
- McDonough P, McKenna JP, McCreary C, Downer EJ. Neuropathic orofacial pain: cannabinoids as a therapeutic avenue. The International Journal of Biochemistry & Cell Biology. 2014; 55: 72–78. - PubMed
-
- Sessle BJ. The societal, political, educational, scientific, and clinical context of orofacial pain. In Sessle BJ (ed). Orofacial pain: recent advances in assessment, management, and understanding of mechanisms (pp. 1–25). IASP Press: Washington. 2014.
-
- Shueb SS, Nixdorf DR, John MT, Alonso BF, Durham J. What is the impact of acute and chronic orofacial pain on quality of life? Journal of Dentistry. 2015; 43: 1203–1210. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources